A clinical trial recently showed that nearly half of individuals with type 2 diabetes achieved remission to a non-diabetic state after a weight-loss intervention delivered within 6 years of diagnosis. Now a study published August 2nd in the journal Cell Metabolism reveals that this successful response to weight loss is associated with the early and sustained improvement in the functioning of pancreatic beta cells. This finding challenges the previous paradigm that beta-cell function is irreversibly lost in patients with type 2 diabetes.
Roy Taylor, Ahmad Al-Mrabeh, Sviatlana Zhyzhneuskaya, Carl Peters, Alison C. Barnes, Benjamin S. Aribisala, Kieren G. Hollingsworth, John C. Mathers, Naveed Sattar, Michael E.J. Lean. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism, 2018; DOI: 10.1016/j.cmet.2018.07.003
Source: Science Daily
(Score: 3, Insightful) by SanityCheck on Saturday August 04 2018, @04:47PM (1 child)
But if you did not take the insulin how was she going to get her kick-back?
(Score: 3, Interesting) by jimbrooking on Saturday August 04 2018, @05:23PM
Indeed - on the following business day I got a call from a "diabetes supply company" to "set up the delivery schedule for your insulin, needles, and test equipment". I filed a HIPAA privacy complaint against the medical center that employed the doctor, for sharing my protected medical information without my consent. The complaint was denied because the supply company was considered a "Provider", as was the doctor, under HIPAA, and provider-to-provider communications don't need patient consent. Nope, she won't be getting any kickbacks based on my purchases. And IMHO the company is no more a "provider" than the hospital toilet paper supplier.